K. Trappe

Carvedilol targets human K2P3.1 (TASK1) K+ leak channels

H. Katus, Ann-Kathrin Rahm, E. Ficker, 2011, British journal of pharmacology.

Is the determination of the defibrillation threshold in patients with an implantable cardioverter–defibrillator still required?

M. Koch, H. Katus, L. Jahn, 2011, Herzschrittmachertherapie + Elektrophysiologie.

Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.

H. Katus, Dierk Thomas, P. Lugenbiel, 2013, European heart journal.

Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.

M. Koch, H. Katus, Dierk Thomas, 2011, Cardiovascular research.

Genetic suppression of Gαs protein provides rate control in atrial fibrillation

H. Katus, Dierk Thomas, P. Lugenbiel, 2012, Basic Research in Cardiology.

Abstract 2101: Genetic Ablation of Atrial Fibrillation in Pigs With Atrial Fibrillation

M. Koch, H. Katus, A. Bauer, 2009 .